Rico Charlène, Fabre Stéphane, Médigue Claire, di Clemente Nathalie, Clément Frédérique, Bontoux Martine, Touzé Jean-Luc, Dupont Mickaël, Briant Eric, Rémy Benoît, Beckers Jean-François, Monniaux Danielle
Physiologie de la Reproduction et des Comportements, UMR 6175 INRA-CNRS-Université de Tours-Haras Nationaux, and Unité Expérimentale de Physiologie Animale de l'Orfrasiére, Centre INRA de Tours, 37380 Nouzilly, France.
Biol Reprod. 2009 Jan;80(1):50-9. doi: 10.1095/biolreprod.108.072157. Epub 2008 Sep 10.
The major limitation to the development of embryo production in cattle is the strong between-animal variability in ovulatory response to FSH-induced superovulation, mainly due to differences in ovarian activity at the time of treatment. This study aimed to establish whether anti-Müllerian hormone (AMH) was an endocrine marker of follicular populations in the cow, as in human, and a possible predictor of the ovarian response to superovulation. Anti-Müllerian hormone concentrations in plasma varied 10-fold between cows before treatment and were found to be highly correlated with the numbers of 3- to 7-mm antral follicles detected by ovarian ultrasonography before treatment (r=0.79, P<0.001) and the numbers of ovulations after treatment (r=0.64, P<0.01). Between-animal differences in AMH concentrations were found to be unchanged after a 3-mo delay (r=0.87, P<0.01), indicating that AMH endocrine levels were characteristic of each animal on a long-term period. The population of healthy 3- to 7-mm follicles was the main target of superovulatory treatments, contained the highest AMH concentrations and AMH mRNA levels compared with larger follicles, and contributed importantly to AMH endocrine levels. In conclusion, AMH was found to be a reliable endocrine marker of the population of small antral gonadotropin-responsive follicles in the cow. Moreover, AMH concentrations in the plasma of individuals were indicative of their ability to respond to superovulatory treatments.
牛胚胎生产发展的主要限制在于,对促卵泡素诱导的超排卵,动物间排卵反应存在很大差异,这主要是由于治疗时卵巢活性不同所致。本研究旨在确定抗苗勒管激素(AMH)是否像在人类中一样,是奶牛卵泡群体的一种内分泌标志物,以及是否是卵巢对超排卵反应的一个可能预测指标。治疗前,奶牛血浆中的抗苗勒管激素浓度相差10倍,且发现其与治疗前通过卵巢超声检测到的3至7毫米窦状卵泡数量高度相关(r = 0.79,P < 0.001)以及治疗后的排卵数量高度相关(r = 0.64,P < 0.01)。发现抗苗勒管激素浓度的动物间差异在延迟3个月后没有变化(r = 0.87,P < 0.01),这表明抗苗勒管激素内分泌水平在长期内是每只动物的特征。健康的3至7毫米卵泡群体是超排卵治疗的主要目标,与较大卵泡相比,其抗苗勒管激素浓度和抗苗勒管激素mRNA水平最高,并且对抗苗勒管激素内分泌水平有重要贡献。总之,发现抗苗勒管激素是奶牛小窦状促性腺激素反应性卵泡群体的可靠内分泌标志物。此外,个体血浆中的抗苗勒管激素浓度表明了它们对超排卵治疗的反应能力。